ANTX
Closed
An2 Therapeutics Inc
1.05
-0.01 (-0.94%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.06
Day's Range: 1.05 - 1.07
Send
sign up or login to leave a comment!
When Written:
9.87
AN2 Therapeutics Inc is a biopharmaceutical company that focuses on developing novel therapies for patients suffering from rare diseases. The company's mission is to improve the lives of patients with rare diseases by developing innovative treatments that target the underlying cause of their conditions. AN2 Therapeutics Inc is headquartered in California, USA, and was founded in 2020. The company's pipeline includes several drug candidates that are in preclinical development for the treatment of rare genetic disorders. AN2 Therapeutics Inc is backed by leading investors in the biotech industry, including Novo Holdings, RA Capital Management, and Samsara BioCapital.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








